Soliton Enlists Chicago Cosmetic Surgery and Dermatology to Advance Pivotal Cellulite Trial Jul 25, 2019
Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement Jul 15, 2019
Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit Jul 2, 2019
Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today Jun 28, 2019
